Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

Luca Incrocci, Ruud Wortel, Wendimagegn Ghidey Alemayehu, Shafak Aluwini, E Schimmel, S Krol, PP van der Toorn, H de Jager, W Heemsbergen, Ben Heijmen, F Pos

Research output: Contribution to journalArticleAcademicpeer-review

313 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1061-1069
Number of pages9
JournalLancet Oncology
Issue number8
Publication statusPublished - 2016

Cite this